About this episode
Yesterday
NVIDIA Posts Earnings. Wall Street Says “That’s It?”
NVIDIA has been the belle of the quarterly earnings ball for quite some time. Investors have been waiting to see how much NIVIDA beat earnings estimates. Even though earnings did beat expectations, the market reaction was “meh”. The gang breaks down NVIDIA’s earnings and investig ... Show More
23m 11s
Feb 25
Who Pays for PayPal?
The market is buzzing with rumors of companies interested in buying Paypal. We look into whether there’s fire behind the smoke. We also cover earnings from Axon and Cava. Travis Hoium, Lou Whiteman, and Rachel Warren discuss: - Potential buyers for PayPal - Axon earnings - Cava E ... Show More
20m 8s
Feb 24
Party Like it’s 2027
Why does the shortest month of the year sometimes feel like the longest? Today on Motley Fool Money, Rick Munarriz and fellow analysts Jason Hall and Travis Hoium, dive into stocks that they are willing to give up our Fool card for. There’s also a look at how we think the percola ... Show More
18m 33s
Sep 2024
#766: The Random Show — Lessons from Tim’s Sabbatical, Alzheimer's Breakthroughs, Kevin Tries a Medium, Fitness Tools and Protocols, Book Recommendations, and More
2h 4m
Oct 2024
Modern Medicine and its Blind Spots — with Dr. Marty Makary
Dr. Marty Makary, a renowned surgeon and professor at Johns Hopkins, public health expert, and a two-time New York Times bestselling author, joins Scott to discuss his latest book, Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health. They go over topics inc ... Show More
51m 8s
Apr 2025
ICYMI: Eli Lilly's New Weight Loss Pill
Shares in Eli Lilly surged on Friday after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ... Show More
7m 16s
Sep 2025
#828: David Senra — How Extreme Winners Think and Win: Lessons from 400+ of History’s Greatest Founders and Investors (Including Buffett, Munger, Rockefeller, Jobs, Ovitz, Zell, and Names You Don’t Know But Should)
2h 55m
Jul 2025
#82 My Billion Dollar Shark Tank Investment: Daymond John
Join Codie Sanchez as she dives deep with Daymond John, the founder of FUBU and a star on Shark Tank, in this insightful episode of the Big Deal podcast. They discuss his journey from starting FUBU in his mom's house to building it into a $6 billion brand, his investment strategi ... Show More
1h 7m
Nov 11
The end of dieting
The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans. This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and ... Show More
25m 50s
Aug 2025
The Biggest Risk Investors Face Today
39m 16s
Apr 2024
#894: Ozempic with James Hamilton
58m 10s
Mar 2022
042 Client Conversations with Dani Wallace and Tom Stanhope
37m 45s
Apr 2025
Francois Rochon - Outperforming the Market for 30+ Years Through Patience, Humility & Rationality | #578
Today’s guest is Francois Rochon, the President of Giverny Capital, which has returned over 15% per year for over 30 years. In today’s episode, Francois walks through the influence of Peter Lynch and Warren Buffett on his investment philosophy. He highlights three principles that ... Show More
1h 4m
$150 billion. That’s how much some experts estimate weight-loss drugs could bring in in sales within the next five years.
Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss:
- How weight-loss drugs actually work, and how big-name prescriptions differ from each other.
- What investors need to know about O ... Show More
<p>This time, we have a very special episode I recorded with my close friend <a href="http://kevinrose.com/" rel="noopener noreferrer" target="_blank"><strong>Kevin Rose</strong></a> in person at his house. We trade our latest discoveries, and I think it’s one of our best. Tons o ... Show More
<p><strong>David Senra </strong>is the host of the <a href="https://www.youtube.com/@founderspodcast1/videos" rel="noopener noreferrer" target="_blank"><strong><em>Founders</em></strong></a> podcast. For the past nine years, David has intensely studied the life and work of hundre ... Show More
<p>Today on <i>The Long View, </i>we’re featuring an episode from another Morningstar podcast, <a href="https://podcasts.apple.com/us/podcast/the-morning-filter/id1792280057" target="_blank"><i>The Morning Filter</i></a><i>, </i>which you can subscribe to on Apple podcasts or whe ... Show More
<p>Ozempic gone wrong!</p>
<p><br></p>
<p>Is the new miracle weight loss drug really the answer to a good old fashioned but of food control? Do we know the true dangers short and long term.</p>
<p><br></p>
<p>James Hamilton joins us this week and walks us through his "experi ... Show More
<p><span style="font-weight: 400;">We're doing something a bit different today as the brilliant Dani Wallace and Tom Stanhope</span> <span style="font-weight: 400;">take over the podcast. </span></p> <p><span style="font-weight: 400;">I've worked with both Dani and Tom for around ... Show More
